Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 294 results found. Search for [ COVID-19 vaccine SII ]

Results 1 to 21 of 294
Rashi Bisaria
New Delhi, March 2, 2021
Expect domestic air passenger traffic to return pre-COVID level by 2022-23, says ICRAExpecting domestic air passenger traffic to return to the pre-COVID-19 level by the financial year 2022-23 and international by 2023-24, rating agency ICRA on Monday said there could be a delay in the commercialisation of expanded capacity by 9-12 months. ICRA also said the cargo volumes are likely to grow around 36 per cent in 2021-22 and six per cent in 2022-23 after a 25 per cent contraction this fiscal, ...


Reuters
March 1, 2021
Some 500,000 doses made by SII, the world's largest vaccine producer, are set to arrive in Canada on Wednesday, a surprise boost for Canada's lagging vaccination drive


Reuters
March 1, 2021
\"The real motivation here is actually exfiltrating intellectual property and getting a competitive advantage over Indian pharmaceutical companies,\" says Cyfirma Chief Executive Kumar Ritesh


Reuters
February 25, 2021
India has vaccinated more than 10.5 million health and front-line workers since beginning its immunisation campaign on January 16


PTI
February 25, 2021
Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume


PB Jayakumar
February 24, 2021
Serum delivered 600,000 doses of Covishield vaccines from Pune to Accra in Ghana. The vaccines arrived on a flight from Mumbai, via Dubai, where the flight also collected a shipment of syringes from a Gavi-funded stockpile at UNICEF's regional supply hub


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


BusinessToday.In
February 21, 2021
Poonawalla appealed to countries and governments to be patient and assured that the coronavirus vaccine will be available to the rest of the world who are purchasing the AstraZeneca-Oxford doses from India


Joe C Mathew
February 19, 2021
Coronavirus vaccine: The Covid-19 vaccine candidate of Novavax is being studied in two ongoing pivotal Phase 3 clinical trials: in the United States and Mexico, as well as in the United Kingdom


BusinessToday.In
February 19, 2021
In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


Reuters
February 9, 2021
Just the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, starting with healthcare and other workers to reach the elderly and those with existing conditions by March


Reuters
February 8, 2021
Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%, researchers said


PB Jayakumar
February 4, 2021
Coronavirus vaccine: India will get the maximum share of 97,164,000 doses (97.1 million), in addition to the direct orders placed by the Indian government with SII and Bharat Biotech


BusinessToday.In
February 4, 2021
The Union Health Ministry has claimed that India has become the fastest country in the world to reach the 4 million vaccination mark in 18 days


PTI
February 2, 2021
Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines


BusinessToday.In
January 30, 2021
Serum Institute of India CEO Adar Poonawalla said the company's tie-up with American vaccine developer Novavax has published 'excellent efficacy results'


BusinessToday.In
January 30, 2021
Coronavirus vaccine: J&J plans to seek emergency use authorisation from the US Food and Drug Administration next week. It has said it plans to deliver 1 billion doses in 2021 and will produce the vaccine in the United States, Europe, South Africa and India


BusinessToday.In
January 29, 2021
Last year in September, Novavax had announced its deal with Serum Institute in order to produce 2 billion doses of COVID-19 vaccines


Reuters
January 29, 2021
Serum expected a decision on an Indian trial of Novavax's vaccine soon, Chief Executive Adar Poonawalla said, hours after the US company reported the efficacy data


PAGES 1 OF 15  12345